(Q33397382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Inhibition of terminal complement activation in severe Shiga toxin-associated HUS - perfect example for a fast track from bench to bedside (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

3

Reinhard Würzner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Magdalena Riedl

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

23 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

EMBO Molecular Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

617-619

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

Eculizumab in severe Shiga-toxin-associated HUS

13 February 2020

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377111

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome

21 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3377111

In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FEMMM.201100169

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FEMMM.201100169

Inhibition of Terminal Complement Complex Formation and Cell Lysis by Monoclonal Antibodies

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21954211

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/EMMM.201100169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21954211%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

21954211

1 reference